论文部分内容阅读
目的探讨舒血宁对急性脑梗死患者临床疗效、神经功能恢复及影响。方法选取我院120例急性发病脑缺血患者随机分为观察组和对照组,各60例,两组患者均按急性脑梗死的常规综合治疗,观察组加用舒血宁注射液,对照组加用丹参注射液,观测神经功能缺损评分和血流变学指标。结果观察组临床治疗效果明显优于对照组;两组梗死体积及神经功能缺损程度评分比较,观察组优于对照组,差异有统计学意义(P<0.05)。结论两种脑神经保护剂在治疗急性脑缺血上均有较好的疗效,两者相比舒血宁注射液治疗急性脑梗塞效果更明显。
Objective To investigate the clinical effects of Shu Xue Ning in patients with acute cerebral infarction, neurological recovery and impact. Methods A total of 120 patients with acute cerebral ischemia in our hospital were randomly divided into observation group and control group, 60 cases in each group. The patients in both groups were treated by conventional comprehensive treatment of acute cerebral infarction. The observation group was treated with Shuxuening injection and the control group Salvia miltiorrhiza injection was added to observe the neurological deficit score and hemorheology indexes. Results The clinical curative effect of the observation group was obviously better than that of the control group. The scores of infarction volume and neurological deficit in the two groups were better than those in the control group (P <0.05). Conclusions Both neuroprotectants have a good curative effect in the treatment of acute cerebral ischemia. Both of them are more effective than Shuxuening injection in treating acute cerebral infarction.